Launch Planning and Implementation Support for Novel Biologic

ClientUS-based emerging biotech
Scope – Global, focus on EU
Company ObjectivesEstablish and support EU price level and reimbursement implementation.

Overcome identified obstacles to maximize return on the compound and maintain narrow price corridor .

Project DescriptionHelp management to design and execute a series of interlocking P&R and market access imperatives. These include:
  • Global pricing policy
  • Core Value Dossier (CVD)
  • Transition from special license sales programs to full market access
  • Support ongoing internal P&R needs of senior management and affiliates
  • Pricing database to monitor developments with other high profile launches
  • Building a decision support tool to prioritize the optimal P&R and launch sequence strategy
  • P&R implications of follow-on indications

Ensure alignment in goals and implementation activities to support them while “translating” between HQ and local European managers.

Project OutcomeAll P&R goals have been exceeded or met to date and company profitability targets exceeded.

Rollout into “second wave” of counties is continuing successfully.